Crossmark

Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice

Crossref DOI link: https://doi.org/10.1007/s00277-025-06255-8

Published Online: 2025-03-01

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pellegrini, Cinzia

Casadei, Beatrice

Broccoli, Alessandro

Cantelli, Martina

Gugliotta, Gabriele

Gentilini, Marianna

Carella, Matteo

Stefoni, Vittorio

Fabbri, Nicole

Gabrielli, Giulia

Argnani, Lisa

Mazzoni, Camilla

Maglio, Pierluca

Bagnato, Gianmarco

Zinzani, Pier Luigi https://orcid.org/0000-0002-2112-2651
Funding

Funding for this research was provided by:

Alma Mater Studiorum - Università di Bologna
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-01
More Information

Article History

Received: 3 January 2025

Accepted: 10 February 2025

First Online: 1 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below